Ocular graft versus host disease in allogenic haematopoetic stem cell transplantation in a tertiary care centre in India

Indian Journal of Medical Research

Volumn 142, Issue NOVEMBER, 2015, Pages 543-548

  Khan, Rehan ^a   Nair, Sridevi ^a   Seth, Tullika ^b   Mishra, Pravas ^b   Mahapatra, Manoranjan ^b   Agarwal, Tushar ^a   Tandon, Radhika ^a   Vanathi, Murugesan ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Bone marrow transplant; Dry eye; Haematopoetic stem cell transplantation; OGVHD; Peripheral blood stem cell transplant

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; FOLINIC ACID; METHOTREXATE; STEROID; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASSESSMENT OF HUMANS; BIOMICROSCOPY; CHILD; CROSS-SECTIONAL STUDY; DRY EYE; FEMALE; GASTROINTESTINAL DISEASE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; INDIA; KNEE MENISCUS RUPTURE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH DISEASE; OCULAR SURFACE DISEASE INDEX SCORE; RISK FACTOR; SCHOOL CHILD; SKIN DISEASE; SLIT LAMP; TERTIARY CARE CENTER; VISUAL ACUITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CROSS-SECTIONAL STUDIES; DRY EYE SYNDROMES; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INDIA; MALE; MIDDLE AGED; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84949563215     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: 10.4103/0971-5916.171280     Document Type: Article

References (34)

1. Lee JW, Deeg HJ. Prevention of chronic GVHD. Best Pract Res Clin Haematol 2008; 21 : 259-70.
2. Jacobs R, Tran U, Chen H, Kassim A, Engelhardt BG, Greer JP, et al. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant 2012; 47 : 1470-3.
3. Riemens A, te Boome L, Imhof S, Kuball J, Rothova A. Current insights into ocular graft-versus-host disease. Curr Opin Ophthalmol 2010; 21 : 485-94.
4. Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH. Acute and chronic graft-versus-host disease after allogeneic peripheral- blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001; 19 : 3685-91.
5. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft - versus - host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11 : 945-56.
6. Mielcarek M, Burroughs L, Leisenring W, Diaconescu R, Martin PJ, Sandmaier BM, et al. Prognostic relevance of ‘early-onset’ graft-versus-host disease following non-myeloablative haematopoietic cell transplantation. Br J Haematol 2005; 129 : 381-91.
7. Ogawa Y, Kuwana M. Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea 2003; 22 (7 Suppl): S19-27.
8. Kosrirukvongs P, Chirapapaisan N, Visuthisakchai S, Issaragrisil S, Gonggetyai V. Sjögren-like syndrome after bone marrow transplantation. J Med Assoc Thai 2008; 91 : 1739-47.
9. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000; 118 : 615-21.
10. Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J 1995; 21 : 221-32.
11. Wang Y, Ogawa Y, Dogru M, Tatematsu Y, Uchino M, Kamoi M, et al. Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye. Bone Marrow Transplant 2010; 45 : 1077-83.
12. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Work Shop (2007). Ocul Surf 2007; 5 : 77-92.
13. Franklin RM, Kenyon KR, Tutschka PJ, Saral R, Green WR, Santos GW. Ocular manifestations of graft-vs-host disease. Ophthalmology 1983; 90 : 4-13.
14. Hirst LW, Jabs DA, Tutschka PJ, Green WR, Santos GW. The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol 1983; 101 : 580-4.
15. Jabs DA, Wingard J, Green WR, Farmer ER, Vogelsang G, Saral R. The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol 1989; 107 : 1343-8.
16. Livesey SJ, Holmes JA, Whittaker JA. Ocular complications of bone marrow transplantation. Eye (Lond) 1989; 3 : 271-6.
17. Calissendorff B, el Azazi M, Lonnqvist B. Dry eye syndrome in long-term follow-up of bone marrow transplanted patients. Bone Marrow Transplant 1989; 4 : 675-8.
18. Bray LC, Carey PJ, Proctor SJ, Evans RG, Hamilton PJ. Ocular complications of bone marrow transplantation. Br J Ophthalmol 1991; 75 : 611-4.
19. Tichelli A, Duell T, Weiss M, Socie G, Ljungman P, Cohen A, et al. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects. Bone Marrow Transplant 1996; 17 : 1105-11.
20. de Marco R, Dassio DA, Vittone P. A retrospective study of ocular side effects in children undergoing bone marrow transplantation. Eur J Ophthalmol 1996; 6 : 436-9.
21. Mencucci R, Rossi Ferrini C, Bosi A, Volpe R, Guidi S, Salvi G. Ophthalmological aspects in allogeneic bone marrow transplantation: Sjögren-like syndrome in graft-versus-host disease. Eur J Ophthalmol 1997; 7 : 13-8.
22. Ogawa Y, Okamoto S, Wakui M, Watanabe R, Yamada M, Yoshino M, et al. Dry eye after hematopoietic stem cell transplantation. Br J Ophthalmol 1999; 83 : 1125-30.
23. Ng JS, Lam DS, Li CK, Chik KW, Cheng GP, Yuen PM, et al. Ocular complications of pediatric bone marrow transplantation. Ophthalmology 1999; 106 : 160-4.
24. Mohty M, Kuentz M, Michallet M, Bourhis JH, Milpied N, Sutton L, et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. Blood 2002; 100 : 3128-34.
25. Leite SC, de Castro RS, Alves M, Cunha DA, Correa ME, da Silveira LA, et al. Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation. Bone Marrow Transplant 2006; 38 : 223-7.
26. Fahnehjelm KT, Törnquist AL, Winiarski J. Dry-eye syndrome after allogeneic stem-cell transplantation in children. Acta Ophthalmol 2008; 86 : 253-8.
27. Tabbara KF, Nassar A, Ahmed SO, Al Mohareb F, Aljurf M. Acquisition of vernal and atopic keratoconjunctivitis after bone marrow transplantation. Am J Ophthalmol 2008; 146 : 462-5.
28. Arain MA, Niazi MK, Khan MD, Ahmed P, Naz MA, Fayyaz M. Frequency of ocular manifestations of chronic graft versus host disease J Ayub Med Coll Abbottabad 2010; 22 : 80-3.
29. Westeneng AC, Hettinga Y, Lokhorst H, Verdonck L, van Dorp S, Rothova A. Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea 2010; 29 : 758-63.
30. Kamoi M, Ogawa Y, Uchino M, Tatematsu Y, Mori T, Okamoto S, et al. Donor-recipient gender difference affects severity of dry eye after hematopoietic stem cell transplantation. Eye (Lond) 2011; 25 : 860-5.
31. Uchino M, Ogawa Y, Uchino Y, Mori T, Okamoto S, Tsubota K. Comparison of stem cell sources in the severity of dry eye after allogeneic haematopoietic stem cell transplantation. Br J Ophthalmol 2012; 96 : 34-7.
32. de la Parra-Colín P, Agahan AL, Pérez-Simón JA, López A, Caballero D, Hernández E, et al. Dry eye disease in chronic graft-versus-host disease: results from a Spanish retrospective cohort study. Transplant Proc 2011; 43 : 1934-8.
33. Dietrich-Ntoukas T, Cursiefen C, Westekemper H, Eberwein P, Reinhard T, Bertz H, et al. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD. Cornea 2012; 31 : 299-310.
34. Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI, et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 2002; 100 : 415-9.